MOBENOL TABLETS 500MG 500 MG
TOLBUTAMIDE : 500 MG · DIN 00013889 · CARTER-HORNER CORP.
Health Canada status: CANCELLED POST MARKET
What is MOBENOL TABLETS 500MG?
MOBENOL TABLETS 500MG 500 MG contains TOLBUTAMIDE : 500 MG. It is listed in the Health Canada Drug Product Database under DIN 00013889, held by CARTER-HORNER CORP., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 14-Aug-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00013889 |
|---|---|
| Brand name | MOBENOL TABLETS 500MG |
| Generic / active ingredient | TOLBUTAMIDE : 500 MG |
| Manufacturer | CARTER-HORNER CORP. |
| Strength | 500 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | A10BB03 TOLBUTAMIDE |
| AHFS class | 08:12.24 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 14-Aug-1997 |
| Original market date | 1971-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A10BB03 TOLBUTAMIDE. 0 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| NOVO-BUTAMIDE 500MG | 500 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 00021849 |
| ORINASE 0.5GM | 500 MG | TABLET | HOECHST CANADA INC. | CANCELLED POST MARKET | DIN 00012602 |
| ORINASE 1GM | 1 G | TABLET | HOECHST CANADA INC. | CANCELLED POST MARKET | DIN 00012610 |
| TOLBUTAMIDE | 500 MG | TABLET | AA PHARMA INC | DORMANT | DIN 00312762 |
| TOLBUTAMIDE TAB 500MG | 500 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00156663 |
| TOLBUTAMIDE TAB 500MG | 500 MG | TABLET | DUCHESNAY INC | CANCELLED POST MARKET | DIN 00431168 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.